title: HIC@RE … and its relevance for a company like RIEMSER.
abstract: The increased incidence of infections caused by methicillin-resistant strains of Staphylococcus aureus (MRSA) burdens the healthcare systems with significant additional costs. Simple measures such as active MRSA screening can lead to a reduction of infectious events and massive savings. To establish an effective and comprehensive strategy for prevention and eradication of MRSA, the cooperation and networking of all stakeholders in the health care system is necessary. Pharmaceutical companies are part of the health care system; they therefore have a vital and ethical interest that care within the health system will be further optimized and thus continue to remain affordable. The targets of the HIC@RE project demonstrate the interests of the pharmaceutical and health-care research company RIEMSER Arzneimittel AG, so that a sufficient rationale is given for cooperation in this project.
authors.affiliation: RIEMSER Arzneimittel AG, Medical Science & Operations, Greifswald - Insel Riems, Germany.
authors.forename: Berno
authors.initials: B
authors.lastname: Müller
authors.forename: Jürgen
authors.initials: J
authors.lastname: Becker